Skip to content
Clinical Trials – home
SpainBack to Spain

Clinical trials in Vitoria – page 7

74 clinical trials in Vitoria, Spain across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Vitoria at a glance
74
clinical trials
  • Research sites3
Type of trial
Recruitment status
Quick filters

74 trials in Vitoria

Open in trial search

Plasma cell myeloma

Not recruiting

Study Comparing Lenalidomide, Bortezomib, Dexamethasone, Isatuximab, and Iberdomide for Newly Diagnosed Multiple Myeloma Patients Eligible for Stem Cell Transplant

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Bortezomib
  • Sponsor:Fundacion PETHEMA

Plasma cell myeloma

Not recruiting

Study on the Effectiveness of Bortezomib, Melphalan, and Prednisone vs. Carfilzomib, Lenalidomide, and Dexamethasone in Older Adults with Newly Diagnosed Multiple Myeloma

Registered drugNo placebo
Countries:SpainSpain
  • Participants:65+ years
  • Substances:Bortezomib
  • Sponsor:Fundacion PETHEMA

Other cities in Spain

The busiest research cities in the country

All 214 cities in Spain

Clinical research in Vitoria

What the registry says about research in the country

01 Oncology Research

Innovative trials focusing on breast cancer treatments, including studies of atezolizumab with chemotherapy and novel approaches for HER2-positive breast cancer. Additional research explores treatments for bladder cancer and pancreatic adenocarcinoma.

  • Triple-negative breast cancer therapy
  • Non-muscle invasive bladder cancer treatment
  • Metastatic cancer interventions

Researchers are evaluating both immunotherapy and targeted treatments to improve patient outcomes.

02 Autoimmune Disorders

Comprehensive studies examining treatments for Sjögren's Syndrome and systemic lupus erythematosus. Research includes evaluation of novel therapies like dazodalibep and efgartigimod for managing autoimmune conditions.

  • Primary Sjögren's Disease treatments
  • Lupus management strategies
  • Innovative biological therapies

Focus on long-term safety and efficacy of new therapeutic approaches.

03 Neurological Conditions

Studies investigating treatments for multiple sclerosis, narcolepsy, and idiopathic hypersomnia. Research includes evaluation of remibrutinib and novel sleep disorder therapies.

  • MS relapse reduction
  • Sleep disorder management
  • Neurological therapeutic advances

Emphasis on developing targeted treatments for better disease control.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.